Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$13.46 - $48.16 $3 Million - $10.7 Million
-222,923 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$34.22 - $47.24 $138,317 - $190,944
4,042 Added 1.85%
222,923 $10.1 Million
Q4 2021

Feb 11, 2022

SELL
$43.29 - $58.77 $91,515 - $124,239
-2,114 Reduced 0.96%
218,881 $10.1 Million
Q3 2021

Nov 09, 2021

BUY
$36.86 - $54.98 $1.85 Million - $2.76 Million
50,211 Added 29.4%
220,995 $10.9 Million
Q2 2021

Aug 11, 2021

SELL
$41.49 - $59.92 $3.83 Million - $5.53 Million
-92,301 Reduced 35.08%
170,784 $8.54 Million
Q1 2021

May 11, 2021

BUY
$46.94 - $58.66 $3.02 Million - $3.77 Million
64,341 Added 32.37%
263,085 $14.3 Million
Q4 2020

Feb 09, 2021

BUY
$42.51 - $64.0 $2.46 Million - $3.71 Million
57,967 Added 41.18%
198,744 $11.3 Million
Q3 2020

Nov 12, 2020

BUY
$49.75 - $60.68 $7 Million - $8.54 Million
140,777 New
140,777 $7.04 Million

Others Institutions Holding OM

About Outset Medical, Inc.


  • Ticker OM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 48,007,300
  • Market Cap $41.3M
  • Description
  • Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...
More about OM
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.